Australia's largest stock trading and investment forum Australia's #1 stock forum

CP1

0.00%

17.0¢ cannpal animal therapeutics limited

A veterinarian's viewpoint, page-5

First 5 Last

Share
Profile

Follow
DD72

3,734 Posts.

487

09/01/20

17:48

Post #: 42307075
Share

Originally posted by dpbear: ↑

Thank you for your kind words. The main advantage I see with CPAT-01 is that the side effects are minimal compared to alternatives that are currently available. When we discuss long term requirements for pain relief, the majority of these patients are in their senior years, especially when you consider osteoarthritis and cancer to name a few common problems. As animals get older, all body systems will slow down especially the kidneys and liver which are important for the processing and eventual elimination of drugs administered. The kidneys and liver are also essential to maintain life. When the liver and kidneys slow down, care must be taken not to harm these organs any further. Currently the most widely used pain relief in animals is a non-steroidal anti-inflammatory drug (NSAID), and long term use is known to cause kidney failure, declining liver function, gastrointestinal problems, and gastric ulcers/perforation. I see CPAT-01 as a breakthrough in being able to provide pain relief to these compromised patients that would otherwise have to be in pain because of their liver/kidney status, or those patients that proceed with NSAIDs for pain relief knowing that the kidneys/liver will be harmed in providing this pain relief. Just like the human population, cats and dogs are also living longer due to technology and medical breakthroughs. 10-20 years ago, life expectancy in dogs was 9-11 years; today it is 15-18 years.

We also encounter very complex cases where pain needs to be managed, but the patient has several pre-existing medical conditions e.g. a dog with Cushings disease that has just ruptured its cruciate ligament. The veterinarian then needs to determine the best way to treat the animal with the least amount of side effects.

Any medical practitioner that is faced with a problem will want to get the best outcome for their patient. The most effective way to do this is to compare various treatment options available, and implement the one with the least number of side effects.

Expand

Hi dpbear, thank you for taking the time to give that analysis and translation It makes it a lot easier to understand what CP1 is offering.

Kind regards

DD

CP1 Price at posting: 16.0¢ Sentiment: None Disclosure: Not Held
3 Upvote

0 Great analysis

Reply

Top Stories

With financials holding the fort, materials must step up with some heavy lifting to stimulate stocks

AML

Cultural heritage agreement puts Walford Creek exploration back on the map

STX

Strike Energy secures $153 million for Perth Basin gas projects

SBW

Shekel Brainweigh CEO Nir Leshem weighs in on AI adoption ahead of FY25

RDN

If you thought lithium was dead, think again. The Pilbara will be central to the next upswing